Skip to main content

Advertisement

SpringerLink
Log in

A Review on the Recent Trend in Osteoporosis Highly Cited Papers

  • Review
  • Published:
Clinical Reviews in Bone and Mineral Metabolism Aims and scope Submit manuscript

Abstract

The goal of this study was to compile the list of highly cited papers in osteoporosis across Web of Science Clarivate Analytics to identify current trends in osteoporosis research. We searched the Web of Science on 18 February 2021 with a search strategy including osteoporosis and all its related keywords. Search results were limited to the highly cited papers published in the last 5 years (2016–2020). Our search strategy on the Web of Science database retrieved 94 highly cited papers, related to osteoporosis. Out of 94 included papers, the biggest portion was secondary studies (44.7%) followed by animals/preclinical studies (31.9%) and primary studies (23.4%). These papers received 12,748 citations with the average 135.6 citations per paper. The main focus of highly cited clinical studies was on interventions (mostly RCTs on newly approved anabolic agents, and on the rebound in vertebral fractures after denosumab discontinuation), followed by topics on risk assessment and epidemiology. The highly cited papers in osteoporosis tend to be secondary studies carried out in the USA with US governmental institutions and pharmaceutical companies grants. These papers reflect several hot topics in osteoporosis including RCTs on anabolic agents during the last 5 years.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

Data Availability

All data used in this paper are available at Web of Science database.

References

  1. NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy. Osteoporosis prevention, diagnosis, and therapy. Jama. 2001;285(6):785–95.

  2. Cooper C, Campion G, Melton LJ 3rd. Hip fractures in the elderly: a world-wide projection. Osteoporos Int. 1992;2(6):285–9.

    CAS  Google Scholar 

  3. Johnell O, Kanis JA. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int. 2006;17(12):1726–33.

    CAS  Google Scholar 

  4. Holroyd C, Cooper C, Dennison E. Epidemiology of osteoporosis. Best Pract Res Clin Endocrinol Metab. 2008;22(5):671–85.

    Google Scholar 

  5. Sözen T, Özışık L, Başaran N. An overview and management of osteoporosis. Eur J Rheumatol. 2017;4(1):46–56.

    Google Scholar 

  6. Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A. Incidence and economic burden of osteoporosis-related fractures in the United States, 2005–2025. J Bone Miner Res. 2007;22(3):465–75.

    Google Scholar 

  7. Hernlund E, Svedbom A, Ivergård M, Compston J, Cooper C, Stenmark J, et al. Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos. 2013;8(1):136.

  8. Cauley JA. Public health impact of osteoporosis. J Gerontol A Biol Sci Med Sci. 2013;68(10):1243–51.

    Google Scholar 

  9. Brüggmann D, Mäule LS, Klingelhöfer D, Schöffel N, Gerber A, Jaque JM, et al. World-wide architecture of osteoporosis research: density-equalizing mapping studies and gender analysis. Climacteric. 2016;19(5):463–70.

    Google Scholar 

  10. Bazrafshan A, Mostafavi E. A Scientometric Overview of 36 Years of Scientific Productivity by Pasteur Institute of Iran in ISI SCIE. Journal of Health Administration. 2011;14(45):7–10.

    Google Scholar 

  11. Gao Q, Zhang C, Wang J, Wei Q, Wei Q, Miyamoto A, et al. The top 100 highly cited articles on osteoporosis from 1990 to 2019: a bibliometric and visualized analysis. Arch Osteoporos. 2020;15(1):144.

    Google Scholar 

  12. Huang Y, Zhao T, Reidler JS, Chen X, Zhang H, Shao H, et al. The top 100 most-cited articles on kyphoplasty and vertebroplasty. World Neurosurg. 2020;135:e435–46.

    Google Scholar 

  13. Das JP, Aherne E, Kavanagh E. Imaging of the spine: a bibliometric analysis of the 100 most-cited articles. Spine (Phila Pa 1976). 2019;44(22):1593–8.

  14. Kavanagh RG, Kelly JC, Kelly PM, Moore DP. The 100 classic papers of pediatric orthopaedic surgery: a bibliometric analysis. J Bone Joint Surg Am. 2013;95(18): e134.

    CAS  Google Scholar 

  15. Mohedano A, Castillo A, de Pablos J, Barrios C. Relevant advances in bone lengthening research: a bibliometric analysis of the 100 most-cited articles published from 2001 to 2017. J Pediatr Orthop B. 2019;28(5):495–504.

    Google Scholar 

  16. He J, He L, Geng B, Xia Y. Bibliometric analysis of the top-cited articles on unicompartmental knee arthroplasty. J Arthroplasty. 2021;36(5):1810-8.e3.

    Google Scholar 

  17. Essential Science Indicators - Highly Cited Papers 2020 [updated 01/16/2020, 2022 May 5]. Available from: http://images.webofknowledge.com/WOKRS535R111/help/WOS/hs_citation_applications.html#dsy7851-TRS_highly_cited_papers. Accessed 20 Dec 2022.

  18. Jaul E, Barron J. Age-related diseases and clinical and public health implications for the 85 years old and over population. Front Public Health. 2017;5:7.

    Google Scholar 

  19. Chen P, Li ZZ, Hu YH. Prevalence of osteoporosis in China: a meta-analysis and systematic review. BMC Public Health. 2016;16:11.

    Google Scholar 

  20. Ballane G, Cauley JA, Luckey MM, Fuleihan GEH. Worldwide prevalence and incidence of osteoporotic vertebral fractures. Osteoporos Int. 2017;28(5):1531–42.

    CAS  Google Scholar 

  21. Lewiecki EM, Wright NC, Curtis JR, Siris E, Gagel RF, Saag KG, et al. Hip fracture trends in the United States, 2002 to 2015. Osteoporos Int. 2018;29(3):717–22.

    Google Scholar 

  22. Borgstrom F, Karlsson L, Ortsater G, Norton N, Halbout P, Cooper C, et al. Fragility fractures in Europe: burden, management and opportunities. Arch Osteoporos. 2020;15(1):21.

    Google Scholar 

  23. Papadimitriou N, Tsilidis KK, Orfanos P, Benetou V, Ntzani EE, Soerjomataram I, et al. Burden of hip fracture using disability-adjusted life-years: a pooled analysis of prospective cohorts in the CHANCES consortium. Lancet Public Health. 2017;2(5):E239–46.

    Google Scholar 

  24. Dyer SM, Crotty M, Fairhall N, Magaziner J, Beaupre LA, Cameron ID, et al. A critical review of the long-term disability outcomes following hip fracture. BMC Geriatr. 2016;16:18.

    Google Scholar 

  25. Cutler RL, Fernandez-Llimos F, Frommer M, Benrimoj C, Garcia-Cardenas V. Economic impact of medication non-adherence by disease groups: a systematic review. BMJ Open. 2018;8(1):13.

    Google Scholar 

  26. Thorning TK, Raben A, Tholstrup T, Soedamah-Muthu SS, Givens I, Astrup A. Milk and dairy products: good or bad for human health? An assessment of the totality of scientific evidence. Food Nutr Res. 2016;60:11.

    Google Scholar 

  27. Balasubramanian A, Zhang J, Chen L, Wenkert D, Daigle SG, Grauer A, et al. Risk of subsequent fracture after prior fracture among older women. Osteoporos Int. 2019;30(1):79–92.

    CAS  Google Scholar 

  28. Yeung SSY, Reijnierse EM, Pham VK, Trappenburg MC, Lim WK, Meskers CGM, et al. Sarcopenia and its association with falls and fractures in older adults: a systematic review and meta-analysis. J Cachexia Sarcopenia Muscle. 2019;10(3):485–500.

    Google Scholar 

  29. Lutsey PL, Norby FL, Ensrud KE, MacLehose RF, Diem SJ, Chen LY, et al. Association of anticoagulant therapy with risk of fracture among patients with atrial fibrillation. JAMA Intern Med. 2020;180(2):245–53.

    CAS  Google Scholar 

  30. Bouxsein ML, Eastell R, Lui LY, Wu LA, de Papp AE, Grauer A, et al. Change in bone density and reduction in fracture risk: a meta-regression of published trials. J Bone Miner Res. 2019;34(4):632–42.

    Google Scholar 

  31. Kanis JA, Harvey NC, Johansson H, Liu EW, Vandenput L, Lorentzon M, et al. A decade of FRAX: how has it changed the management of osteoporosis? Aging Clin Exp Res. 2020;32(2):187–96.

    Google Scholar 

  32. Kanis JA, Harvey NC, Cooper C, Johansson H, Oden A, McCloskey EV, et al. A systematic review of intervention thresholds based on FRAX a report prepared for the National Osteoporosis Guideline Group and the International Osteoporosis Foundation. Arch Osteoporos. 2016;11(1):48.

    Google Scholar 

  33. McCloskey EV, Oden A, Harvey NC, Leslie WD, Hans D, Johansson H, et al. A meta-analysis of trabecular bone score in fracture risk prediction and its relationship to FRAX. J Bone Miner Res. 2016;31(5):940–8.

    Google Scholar 

  34. Samelson EJ, Broe KE, Xu HF, Yang LJ, Boyd S, Biver E, et al. Cortical and trabecular bone microarchitecture as an independent predictor of incident fracture risk in older women and men in the Bone Microarchitecture International Consortium (BoMIC): a prospective study. Lancet Diabetes Endocrinol. 2019;7(1):34–43.

    Google Scholar 

  35. Shepstone L, Lenaghan E, Cooper C, Clarke S, Fong-Soe-Khioe R, Fordham R, et al. Screening in the community to reduce fractures in older women (SCOOP): a randomised controlled trial. Lancet. 2018;391(10122):741–7.

    Google Scholar 

  36. Peng K, Yang M, Tian M, Chen M, Zhang J, Wu X, et al. Cost-effectiveness of a multidisciplinary co-management program for the older hip fracture patients in Beijing. Osteoporos Int. 2020;31(8):1545–53.

    CAS  Google Scholar 

  37. Villareal DT, Aguirre L, Gurney AB, Waters DL, Sinacore DR, Colombo E, et al. Aerobic or resistance exercise, or both, in dieting obese older adults. N Engl J Med. 2017;376(20):1943–55.

    Google Scholar 

  38. Weaver CM, Alexander DD, Boushey CJ, Dawson-Hughes B, Lappe JM, LeBoff MS, et al. Calcium plus vitamin D supplementation and risk of fractures: an updated meta-analysis from the National Osteoporosis Foundation. Osteoporos Int. 2016;27(1):367–76.

    CAS  Google Scholar 

  39. Zhao JG, Zeng XT, Wang J, Liu L. Association between calcium or vitamin D supplementation and fracture incidence in community-dwelling older adults a systematic review and meta-analysis. JAMA-J Am Med Assoc. 2017;318(24):2466–82.

    CAS  Google Scholar 

  40. Kahwati LC, Weber RP, Pan HL, Gourlay M, LeBlanc E, Coker-Schwimmer M, et al. Vitamin D, calcium, or combined supplementation for the primary prevention of fractures in community-dwelling adults evidence report and systematic review for the US preventive services task force. JAMA-J Am Med Assoc. 2018;319(15):1600–12.

    Google Scholar 

  41. Burt LA, Billington EO, Rose MS, Raymond DA, Hanley DA, Boyd SK. Effect of high-dose vitamin D supplementation on volumetric bone density and bone strength a randomized clinical trial. JAMA-J Am Med Assoc. 2019;322(8):736–45.

    CAS  Google Scholar 

  42. Lobo RA. Hormone-replacement therapy: current thinking. Nat Rev Endocrinol. 2017;13(4):220–31.

    CAS  Google Scholar 

  43. Marjoribanks J, Farquhar C, Roberts H, Lethaby A, Lee J. Long-term hormone therapy for perimenopausal and postmenopausal women. Cochrane Database Syst Rev. 2017;1:224.

    Google Scholar 

  44. Barrionuevo P, Kapoor E, Asi N, Alahdab F, Mohammed K, Benkhadra K, et al. Efficacy of pharmacological therapies for the prevention of fractures in postmenopausal women: a network meta-analysis. J Clin Endocrinol Metab. 2019;104(5):1623–30.

    Google Scholar 

  45. Cosman F, Crittenden DB, Adachi JD, Binkley N, Czerwinski E, Ferrari S, et al. Romosozumab treatment in postmenopausal women with osteoporosis. N Engl J Med. 2016;375(16):1532–43.

    CAS  Google Scholar 

  46. Saag KG, Petersen J, Brandi ML, Karaplis AC, Lorentzon M, Thomas T, et al. Romosozumab or alendronate for fracture prevention in women with osteoporosis. N Engl J Med. 2017;377(15):1417–27.

    CAS  Google Scholar 

  47. Langdahl BL, Libanati C, Crittenden DB, Bolognese MA, Brown JP, Daizadeh NS, et al. Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: a randomised, open-label, phase 3 trial. Lancet. 2017;390(10102):1585–94.

    CAS  Google Scholar 

  48. Kendler DL, Marin F, Zerbini CAF, Russo LA, Greenspan SL, Zikan V, et al. Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial. Lancet. 2018;391(10117):230–40.

    CAS  Google Scholar 

  49. Miller PD, Hattersley G, Riis BJ, Williams GC, Lau E, Russo LA, et al. Effect of abaloparatide vs placebo on new vertebral fractures in postmenopausal women with osteoporosis a randomized clinical trial. JAMA-J Am Med Assoc. 2016;316(7):722–33.

    CAS  Google Scholar 

  50. Reid IR, Horne AM, Mihov B, Stewart A, Garratt E, Wong S, et al. Fracture prevention with zoledronate in older women with osteopenia. N Engl J Med. 2018;379(25):2407–16.

    CAS  Google Scholar 

  51. Bone HG, Wagman RB, Brandi ML, Brown JP, Chapurlat R, Cummings SR, et al. 10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension. Lancet Diabetes Endocrinol. 2017;5(7):513–23.

    CAS  Google Scholar 

  52. Anastasilakis AD, Polyzos SA, Makras P, Aubry-Rozier B, Kaouri S, Lamy O. Clinical features of 24 patients with rebound-associated vertebral fractures after denosumab discontinuation: Systematic review and additional cases. J Bone Miner Res. 2017;32(6):1291–6.

    CAS  Google Scholar 

  53. Tsourdi E, Langdahl B, Cohen-Solal M, Aubry-Rozier B, Eriksen EF, Guanabens N, et al. Discontinuation of denosumab therapy for osteoporosis: a systematic review and position statement by ECTS. Bone. 2017;105:11–7.

    Google Scholar 

  54. Cummings SR, Ferrari S, Eastell R, Gilchrist N, Jensen JEB, McClung M, et al. Vertebral fractures after discontinuation of denosumab: a post hoc analysis of the randomized placebo-controlled FREEDOM trial and its extension. J Bone Miner Res. 2018;33(2):190–8.

    CAS  Google Scholar 

  55. Clark W, Bird P, Gonski P, Diamond TH, Smerdely P, McNeil HP, et al. Safety and efficacy of vertebroplasty for acute painful osteoporotic fractures (VAPOUR): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet. 2016;388(10052):1408–16.

    Google Scholar 

  56. Firanescu CE, de Vries J, Lodder P, Venmans A, Schoemaker MC, Smeet AJ, et al. Vertebroplasty versus sham procedure for painful acute osteoporotic vertebral compression fractures (VERTOS IV): randomised sham controlled clinical trial. BMJ-British Medical Journal. 2018;361:9.

    Google Scholar 

  57. Liu MX, Xia L, Zhong J, Dou NN, Li B. Is it necessary to approach the compressed vertebra bilaterally during the process of PKP? J Spinal Cord Med. 2020;43(2):201–5.

    Google Scholar 

  58. Highly Cited Papers. InCites Help: Clarivate Analytics; [cited 28 May 2022]. Available from: http://help.prod-incites.com/inCites2Live/indicatorsGroup/aboutHandbook/usingCitationIndicatorsWisely/highlyCitedPapers.html. Accessed 20 Dec 2022.

  59. Geraei E, Mazaheri E, Karimi M. Intradepartment scientific collaboration in Journal of Research in Medical Sciences: A co-authorship study. J Res Med Sci. 2018;23:97.

  60. Nabout JC, Parreira MR, Teresa FB, Carneiro FM, da Cunha HF, de Souza OL, et al. Publish (in a group) or perish (alone): the trend from single- to multi-authorship in biological papers. Scientometrics. 2015;102(1):357–64.

    Google Scholar 

  61. Number of Authors per MEDLINE®/ PubMed® Citation. Bethesda (MD): National Library of Medicine (US), Bibliographic Services Division. 2020. Available from: https://www.nlm.nih.gov/bsd/authors1.html. Accessed 20 Dec 2022.

  62. Fewster-Thuente L, Velsor-Friedrich B. Interdisciplinary collaboration for healthcare professionals. Nurs Adm Q. 2008;32(1):40–8.

    Google Scholar 

Download references

Funding

This work was supported by Endocrine & Metabolism Research Institute, Tehran University of Medical Sciences.

Author information

Author notes

  1. Mohammad Javad Mansourzadeh and Nekoo Panahi shared first authorship.

Authors and Affiliations

  1. Osteoporosis Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran

    Mohammad Javad Mansourzadeh, Noushin Fahimfar, Hamed Moheimani, Mahnaz Sanjari, Kazem Khalagi & Afshin Ostovar

  2. Prevention of Metabolic Disorders Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran

    Mohammad Javad Mansourzadeh

  3. Metabolic Disorders Research Center, Endocrinology and Metabolism Molecular -Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran

    Nekoo Panahi

  4. Evidence Based Medicine Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran

    Maryam Aalaa & Akbar Soltani

  5. Obesity and Eating Habits Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran

    Kazem Khalagi

  6. Center for Non-Communicable Disease Control & Prevention, Deputy of Public Health, Ministry of Health and Medical Education, Tehran, Iran

    Fatemeh Hajivalizadeh

  7. Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran

    Afshin Ostovar

  8. Department of e-Learning in Medical Education, Center of Excellence for e-Learning in Medical Education, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

    Maryam Aalaa

Authors
  1. Mohammad Javad Mansourzadeh
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nekoo Panahi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Noushin Fahimfar
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hamed Moheimani
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Maryam Aalaa
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Mahnaz Sanjari
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Kazem Khalagi
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Fatemeh Hajivalizadeh
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Afshin Ostovar
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Akbar Soltani
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

All authors contributed to the study conception and design. Material preparation and data collection were performed by MJM and HM. The critical appraisal of the papers was done by NP and HM, and disagreement between the reviewers was resolved by NF. Scientometric analysis was performed by MJM and content analysis was done by NP, HM, and NF. The first draft of the manuscript was written by MJM, NP, and NF, and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.

Corresponding authors

Correspondence to Noushin Fahimfar or Akbar Soltani.

Ethics declarations

Ethics Approval

The article does not contain any studies with human or animal subjects performed by the any of the authors.

Conflict of Interest

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mansourzadeh, M.J., Panahi, N., Fahimfar, N. et al. A Review on the Recent Trend in Osteoporosis Highly Cited Papers. Clinic Rev Bone Miner Metab 20, 1–9 (2022). https://doi.org/10.1007/s12018-022-09285-2

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12018-022-09285-2

Keywords

Search

Navigation